GRAZIOSO, GIOVANNI
GRAZIOSO, GIOVANNI
Dipartimento di Scienze Farmaceutiche
A Novel Approach to Target a Previously Unexplored Pocket in PI3Kgamma
2026 A. Casale, A. Mainetti, G. Antonini, G. Grazioso, C. Borsari
Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents
2026 A. Morales, A. Cruz, Á. Pérez-Sánchez, D. D'Avino, G. Galassi, E.G. Milano, I. Bernareggi, C. Arenós-Bach, G. Grazioso, R. Alibés, J. Hernando, P. Gorostiza, A. Rossi, A. Pistocchi, C. Matera, F. Busqué, À. González-Lafont, J.M. Lluch
Insights into the catalytic mechanism of formate dehydrogenases from different microbial sources
2026 L. Legnani, M. Gargiulo, E. Lio, E.M.A. Fassi, G. Grazioso, M.A. Chiacchio, B. Binay, S. Brocca, F. Secundo
PCSK9 inhibitors: an updated patent review 2024–2025
2026 E.M.A. Fassi, M. Albani, L. D'Adduzio, E.G. Milano, C. Lammi, G. Grazioso
Modulatori Fotosensibili dell’adesione batterica: una nuova strategia per ridurre l’antibiotico-resistenza
2025 A. Colleoni, G. Tempra, S. Bhattacharya, E.M.A. Fassi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
Design and synthesis of CD70 inhibitors: a potential way for the treatment of ulcerative colitis
2025 M. Galli, A. Silvani, G. Grazioso, E.G. Milano, E.M.A. Fassi, M. Bramuzzo, A. Muzzo, G. Stocco, M. Lucafò
Spatiotemporal Control of Bacterial Adhesion via Light-Responsive Modulators
2025 A. Colleoni, G. Tempra, S. Bhattacharya, E.M.A. Fassi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation
2025 M. Mori, E.M.A. Fassi, F. Villa, E.G. Milano, F. Forlani, F. Cappitelli, A. Ratti, F. Meneghetti, G. Roda, G. Grazioso, S. Villa
A potent nonapeptide inhibitor for the CXCL12/HMGB1 heterocomplex: A computational and experimental approach
2025 E.M.A. Fassi, E. Pirani, V. Cecchinato, A. Cavalli, G. Roda, M. Uguccioni, J. Sgrignani, G. Grazioso
Light-Responsive Modulators of Bacterial Cell Adhesion Proteins: a Novel Strategy against AMR?
2025 A. Colleoni, G. Tempra, S. Bhattacharya, E.M.A. Fassi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment
2025 M. Voi, A. Sangalli, E.G. Milano, C. De Martinis, E. Orlandi, S. Tamburin, E. Mantovani, A. Federico, M. Lanzafame, E. Lattuada, G.A. Argañaraz, B.C.M. Da Silva, A.J. Da Silva Duarte, J. Casseb, E.R. Argañaraz, M. Malena, M. Albani, A. Ruggiero, M.G. Romanelli, M.T. Valenti, G. Grazioso, D. Zipeto
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation
2025 G. Cazzaniga, D. Capelli, R. Montanari, E.M.A. Fassi, G. Grazioso, A. Tresoldi, F. Rinaldi, E. Calleri, I. Bassanini, S. Romeo, M. Garofalo, M. Mori, F. Meneghetti, S. Villa
Insights on Zosteric Acid Analogues Activity Against Candida albicans Biofilm Formation
2025 C. Catto', E.M.A. Fassi, G. Grazioso, A. Gelain, S. Villa, F. Cappitelli
Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics
2025 E.M.A. Fassi, N. Mekni, M. Albani, S. Maehrlein, A.C. Weldert, T. Schirmeister, T. Langer, G. Grazioso
FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer
2025 E.M.A. Fassi, R.M. Moretti, M. Montagnani Marelli, M. Garofalo, A. Gori, C. Pesce, M. Albani, E.G. Milano, J. Sgrignani, A. Cavalli, G. Grazioso
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists
2024 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, E.M.A. Fassi, G. Grazioso, F. Meneghetti, S. Villa
Novel Non-peptide Uracil-derived Human Gonadotropin-Releasing Hormone Receptor Antagonists
2024 S. Ciceri, E.M.A. Fassi, V. Vezzoli, M. Bonomi, D. Colombo, P. Ferraboschi, G. Grazioso, P. Grisenti, S. Villa, C. Castellano, F. Meneghetti
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines
2024 M. Albani, E.M.A. Fassi, R.M. Moretti, M. Garofalo, M. Montagnani Marelli, G. Roda, J. Sgrignani, A. Cavalli, G. Grazioso
PCSK9 inhibitors: a patent review 2018-2023
2024 E.M.A. Fassi, A. Citarella, M. Albani, E.G. Milano, L. Legnani, C. Lammi, A. Silvani, G. Grazioso
Insights on the atropisomeric properties of elagolix and its derivatives
2023 S. Ciceri, D. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti